San Francisco, United States
Probably Genetic, founded in 2022 and based in the United States, is on a mission to provide rapid diagnosis solutions for the 400 million people globally suffering from rare genetic diseases. With their slogan, "Helping people with rare genetic diseases get answers", Probably Genetic addresses a pressing health issue: the extensive average delay of 5-7 years in diagnosing rare diseases.
Utilizing cutting-edge machine learning, the company's online Symptom Checker efficiently identifies potential rare disease patients, accelerating the diagnostic process to mere weeks. Their direct-to-consumer genetic testing service not only aids in faster diagnosis but also connects patients to critical treatment options and support networks. Partnerships with drug developers facilitate low-cost access to essential genetic testing.
Most recently, Probably Genetic has secured a $10.70M Early VC investment as of 01 November 2023, signaling strong investor confidence in their innovative health tech solutions.
